Glaucoma Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class (Prostaglandins, Beta Blockers, Alpha Agonists, Carbonic Anhydrase Inhibitors, Combination Medications, Cholinergics); End Use (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers) and Geography
Report Code: TIPRE00018828 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Glaucoma is a type of eye condition that damage optic nerve, the health of optic nerve is very crucial for clear vision. Glaucoma usually occurs by abnormal high pressure (Intraocular pressure) in the eye. Glaucoma can affect people of any age but is common in elderly population. The symptoms of glaucoma include, patchy blind spot, severe headache, blurred vision, eye redness. Glaucoma therapeutics are the agents which used in management of glaucoma.
MARKET DYNAMICS
The key market drivers for Glaucoma Therapeutics Market Includes, rising geriatric population across the globe along with increasing incidences of glaucoma across the globe. Moreover, high R&D investments by pharma companies to develop novel therapies for maintaining strong pipeline of therapeutic agents is also expected to fuel market growth. Additionally, rising healthcare expenditure is also expected to boost market growth. Whereas, side effects from drug therapies along with drug recalls by major players is expected to restrain market growth.
MARKET SCOPE
The "Glaucoma Therapeutics Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Glaucoma Therapeutics market with detailed market segmentation by drug class and end use. The Glaucoma Therapeutics Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Glaucoma Therapeutics Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Glaucoma Therapeutics Market is segmented on the basis of drug class and end use. On the basis of drug class the market is segmented as, prostaglandins, beta blockers, alpha agonists, carbonic anhydrase inhibitors, cholinergic. And on the basis of end use the market is segmented as, hospitals, ophthalmic clinics, and ambulatory surgical centers.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Glaucoma Therapeutics Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Glaucoma Therapeutics Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Glaucoma Therapeutics Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Glaucoma Therapeutics Market in these regions.
The report covers key developments in the Glaucoma Therapeutics Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Glaucoma Therapeutics Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Glaucoma Therapeutics market in the global market. Below mentioned is the list of few companies engaged in the Glaucoma Therapeutics Market.
The report also includes the profiles of key players in Glaucoma Therapeutics Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Merck and Co, Inc.
- Allergan Plc.
- Bausch and Lomb Incorporated
- Teva Pharmaceuticals
- Valeant Pharmaceuticals
- Santen Pharmaceuticals
- Aerie Pharmaceuticals
- Aristo Pharmaceuticals
- Novartis AG
- Pfizer, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Glaucoma is a type of eye condition that damage optic nerve, the health of optic nerve is very crucial for clear vision. Glaucoma usually occurs by abnormal high pressure (Intraocular pressure) in the eye. Glaucoma can affect people of any age but is common in elderly population. The symptoms of glaucoma include, patchy blind spot, severe headache, blurred vision, eye redness. Glaucoma therapeutics are the agents which used in management of glaucoma.
MARKET DYNAMICS
The key market drivers for Glaucoma Therapeutics Market Includes, rising geriatric population across the globe along with increasing incidences of glaucoma across the globe. Moreover, high R&D investments by pharma companies to develop novel therapies for maintaining strong pipeline of therapeutic agents is also expected to fuel market growth. Additionally, rising healthcare expenditure is also expected to boost market growth. Whereas, side effects from drug therapies along with drug recalls by major players is expected to restrain market growth.
MARKET SCOPE
The "Glaucoma Therapeutics Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Glaucoma Therapeutics market with detailed market segmentation by drug class and end use. The Glaucoma Therapeutics Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Glaucoma Therapeutics Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Glaucoma Therapeutics Market is segmented on the basis of drug class and end use. On the basis of drug class the market is segmented as, prostaglandins, beta blockers, alpha agonists, carbonic anhydrase inhibitors, cholinergic. And on the basis of end use the market is segmented as, hospitals, ophthalmic clinics, and ambulatory surgical centers.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Glaucoma Therapeutics Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Glaucoma Therapeutics Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Glaucoma Therapeutics Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Glaucoma Therapeutics Market in these regions.
The report covers key developments in the Glaucoma Therapeutics Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Glaucoma Therapeutics Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Glaucoma Therapeutics market in the global market. Below mentioned is the list of few companies engaged in the Glaucoma Therapeutics Market.
The report also includes the profiles of key players in Glaucoma Therapeutics Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Merck and Co, Inc.
- Allergan Plc.
- Bausch and Lomb Incorporated
- Teva Pharmaceuticals
- Valeant Pharmaceuticals
- Santen Pharmaceuticals
- Aerie Pharmaceuticals
- Aristo Pharmaceuticals
- Novartis AG
- Pfizer, Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
The List of Companies
1. Merck and Co, Inc
2. Novartis AG
3. Allergan plc
4. Bausch and Lomb Incorporated
5. Teva Pharmaceuticals
6. Pfizer, Inc
7. Valeant Pharmaceuticals
8. Santen Pharmaceuticals
9. Aerie Pharmaceuticals
10. Aristo Pharmaceuticals
1. Merck and Co, Inc
2. Novartis AG
3. Allergan plc
4. Bausch and Lomb Incorporated
5. Teva Pharmaceuticals
6. Pfizer, Inc
7. Valeant Pharmaceuticals
8. Santen Pharmaceuticals
9. Aerie Pharmaceuticals
10. Aristo Pharmaceuticals
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount